Journal of Ophthalmology / 2016 / Article / Tab 1

Clinical Study

Long-Term Observation of Triplex Surgery for Cataract after Phakic 6H Implantation for Super High Myopia

Table 1

Baseline clinical data before and after phakic 6H AC pIOL implantation in eyes that developed cataract and underwent the triplex surgery.

Case/eyeSex/age (y) AL (mm) ACD (mm) CCT (µm) WTW (mm) SE Phakic 6H AC pIOL ECD (cells/mm2)⁢ BCVA
(logMAR)
Time between PSR surgery and phakic 6H implantation (y)  Time between phakic 6H implantation and triplex surgery (y)
PrePostPowerOptic diameter (mm)PrePost (6 m) PrePost

1/RF/4231.943.6250111.3−21.50−2.00−19.5012.5285225300.520.303.06.5
1/L31.643.3449711.3−21.50−1.50−19.5012.5270924510.520.303.06.5
2/RF/3531.043.5251011.9−15.00−0.50−14.0012.5240321030.100.10None6.0
2/L30.673.3849211.8−14.00−1.25−13.0012.5205021000.220.22None6.0
3/RF/3829.093.7051912.0−15.50+0.50−15.5013.0269825790.150.005.07.0
3/L31.133.6750711.7−20.50−0.75−19.5012.5254325410.400.225.07.0
4/RF/4731.093.5850712.1−15.50+0.50−15.0013.0295427050.050.001.57.0
4/L29.753.7451312.1−13.75−1.00−13.5013.0301028280.000.001.57.8
5/LF/4533.753.6255812.7−18.50−2.25−17.5013.5292227490.150.00None8.3
6/RF/3932.513.6655411.6−25.000.00−23.5012.5232225450.520.227.58.3
6/L32.39 3.8954611.6−27.00−0.75−23.5012.5290027080.520.227.56.3
7/RM/4433.723.8952711.8−22.00−0.25−19.0012.5237323841.300.70None4.0
8/RF/3132.593.5358911.5−22.75−1.00−21.0012.5273426990.400.30None5.5
8/L32.413.5457411.4−22.00−0.75−20.5012.5319530580.400.30None5.8
9/LF/2731.583.1853711.4−26.00−3.00−22.0012.5276926810.700.70None5.0
10/LF/3730.733.6254011.6−19.000.00−18.0012.5273024860.820.406.58.3
Mean (SD)38.5 (6.3)31.63 (1.28)3.59 (0.19)529 (29)11.7 (0.4)−19.97 (4.27)−0.89 (0.95)−18.41 (3.40)12.7 (0.3)2698 (296)2572 (245)0.42 (0.33)0.25 (0.22)4.5 (2.4)6.6 (1.2)

AL: axial length; ACD: anterior chamber depth (including corneal thickness); CCT: central corneal thickness; WTW: white to white; SE: spherical equivalent; Pre: before phakic 6H AC pIOL implantation; Post: after phakic 6H AC pIOL implantation; ECD: endothelial cell density; BCVA: best corrected visual acuity; SE: spherical equivalent; PSR: posterior scleral reinforcement surgery; m: month(s).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.